Loading...
Patently unpatentable: implications of the Myriad court decision on genetic diagnostics
The recent decision in the case Association for Molecular Pathology et al. v. United States Patent and Trademark Office et al. shocked the biotechnology industry. Although the case could be overturned on appeal, it will likely change how gene patents are written. The effects of the decision may be m...
Na minha lista:
| Hovedforfatter: | |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2010
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2955823/ https://ncbi.nlm.nih.gov/pubmed/20832881 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.tibtech.2010.08.005 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|